Veradigm, Inc. engages in the provision of clinical, financial, and operational results services. The company is headquartered in Chicago, Illinois and currently employs 2,450 full-time employees. The firm's Veradigm Network provides advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. Its portfolio offers comprehensive solutions that help clients to advance healthcare by providing electronic health records (EHR), financial management, population health management, deidentified data and patient communication solutions. Its Provider business consists of two EHRs, practice management and revenue cycle management, which are patient engagement and enterprise resource planning solutions. Its Payer business delivers end-to-end solutions for health plans, from analytics and data to engagement solutions. Its Life Science Business includes a data and research platform and a commercial media business, which partners with life science and other healthcare companies and their respective brand agencies to deliver media, advertising and education to clinicians.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenue
588
588
1,503
1,502
1,632
1,617
Revenue Growth (YoY)
-28%
-61%
0%
-8%
1%
8%
Cost of Revenue
279
279
883
937
1,022
996
Gross Profit
308
308
619
565
610
621
Selling, General & Admin
168
168
313
389
400
432
Research & Development
97
97
193
206
245
258
Operating Expenses
327
327
530
621
673
718
Other Non Operating Income (Expenses)
-21
-21
87
0
-138
0
Pretax Income
-63
-63
161
-149
-281
-62
Income Tax Expense
-43
-43
27
-16
-40
-19
Net Income
-86
-86
134
700
-182
363
Net Income Growth
-164%
-164%
-81%
-484.99%
-150%
-285%
Shares Outstanding (Diluted)
108.05
112.07
138.7
159.3
166.3
176
Shares Change (YoY)
-16%
-19%
-13%
-4%
-6%
-3%
EPS (Diluted)
-0.79
-0.77
0.97
4.39
-1.09
2.06
EPS Growth
-175%
-179%
-78%
-503%
-153%
-291%
Free Cash Flow
83
83
-154
-211
-84
-76
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
52.38%
52.38%
41.18%
37.61%
37.37%
38.4%
Operating Margin
-3.23%
-3.23%
5.92%
-3.72%
-3.86%
-5.93%
Profit Margin
-14.62%
-14.62%
8.91%
46.6%
-11.15%
22.44%
Free Cash Flow Margin
14.11%
14.11%
-10.24%
-14.04%
-5.14%
-4.7%
EBITDA
96
96
265
136
144
96
EBITDA Margin
16.32%
16.32%
17.63%
9.05%
8.82%
5.93%
D&A For EBITDA
115
115
176
192
207
192
EBIT
-19
-19
89
-56
-63
-96
EBIT Margin
-3.23%
-3.23%
5.92%
-3.72%
-3.86%
-5.93%
Effective Tax Rate
68.25%
68.25%
16.77%
10.73%
14.23%
30.64%
Follow-Up Questions
What are Veradigm Inc's key financial statements?
According to the latest financial statement (Form-10K), Veradigm Inc has a total asset of $1,504, Net loss of $-86
What are the key financial ratios for MDRX?
Veradigm Inc's Current ratio is 3.08, has a Net margin is -14.62, sales per share of $5.24.
How is Veradigm Inc's revenue broken down by segment or geography?
Veradigm Inc largest revenue segment is Pharmaceutical, at a revenue of 58,142,000,000 in the most earnings release.For geography, United States is the primary market for Veradigm Inc, at a revenue of 36,510,000,000.
Is Veradigm Inc profitable?
no, according to the latest financial statements, Veradigm Inc has a net loss of $-86
Does Veradigm Inc have any liabilities?
yes, Veradigm Inc has liability of 487
How many outstanding shares for Veradigm Inc?
Veradigm Inc has a total outstanding shares of 106.07